BioCentury
ARTICLE | Clinical News

Pfizer preclinical data

July 26, 2010 7:00 AM UTC

In mouse models of hemophilia, Pfizer's activated recombinant Factor Xa variant corrected bleeding. Data were presented at the World Federation of Hemophilia Congress in Buenos Aires. ...